AMEBA Amoeba SA

Edison issues report on Amoéba (ALMIB)

Edison Investment Research Limited
Edison issues report on Amoéba (ALMIB)

21-Jun-2024 / 12:36 GMT/BST
The issuer is solely responsible for the content of this announcement.

 

London, UK, 21 Juni 2024

 

Edison issues report on Amoéba (ALMIB)

to view the full report.

All reports published by Edison are available to download free of charge from its website

Edison is authorised and regulated by the .

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison’s reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

+44 (0)20 3077 5700

Connect with Edison on:

 

LinkedIn 

X  

YouTube 


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
End of Announcement - EQS News Service

1930811  21-Jun-2024 

fncls.ssp?fn=show_t_gif&application_id=1930811&application_name=news&site_id=research_pool~~~9efe1c65-8ece-4ff7-9608-f21c8e0a38a3
EN
21/06/2024

Underlying

AMEBAAmoeba SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Amoeba SA

Guy Sips
  • Guy Sips
AMEBA AMOEBA SA

Amoéba Presenting the 2025 results of its vineyard trial campaign

We welcome AXPERA confirms its effectiveness against downy mildew and its strong potential to significantly reduce copper use. These field trials were confirming AXPERA's strong performance in real conditions. Amoéba presented nice results of its 2025 vineyard trial campaign confirming AXPERA's effectiveness against downy mildew, as observed in previous years — and particularly in 2024, a season during which the disease proved especially virulent. The results obtained in 2025 confirm that the in...

10/29/25 October 29, 2025 1 EN
Guy Sips
  • Guy Sips
AMEBA AMOEBA SA

Amoéba Obtaining market authorisation in US for its AXPERA biocontrol ...

We welcome Amoéba's first two biocontrol fungicides, AXPERA NOA and AXPERA GREEN, received approval from the US Environmental Protection Agency (US EPA) for the first crops targeted by Amoéba. Amoéba also indicated it is progressing in line with its strategic plan to begin marketing its biocontrol solution in Europe and the US in 2026. Amoéba announced that it has received regulatory approval from the US Environmental Protection Agency (EPA) to market in the US its biocontrol products AXPERA N...

10/17/25 October 17, 2025 1 EN
Guy Sips
  • Guy Sips
AMEBA AMOEBA SA

Amoéba Setting up Green 4 Agro, structuring its activities in biocontr...

Amoéba takes a further step in the structuring of its activities in the area of biocontrol, confirming its ambition to become a key player in the agroecological transition by setting up Green 4 Agro, its subsidiary dedicated to the commercialisation and development of its biocontrol and biostimulant solutions. As a reminder, commercial operations will begin in 2026 with the distribution of its AXPERA biocontrol solution for vineyards and vegetable crops, through its first partner, Koppert. Green...

10/16/25 October 16, 2025 1 EN
Guy Sips
  • Guy Sips
AMEBA AMOEBA SA

Amoéba Now full speed ahead to commercial launch of its biocontrol sol...

First-half result numbers overshadowed by the various milestones achieved over the past two years by its biocontrol solution (with final approval of the active substance by the European Commission and the signing of a strategic distribution agreement with Koppert) now enables them to launch its commercialisation in 2026. The US EPA (Environmental Protection Agency) decision on the application for federal marketing authorisation in the US for AXPERA, which has been delayed for reasons beyond Amoé...

10/10/25 October 10, 2025 1 EN
Guy Sips
  • Guy Sips
AMEBA AMOEBA SA

Amoéba Very convincing results observed by winegrowers

Amoéba announced positive results of its wine-growing trials in France and Europe. Amoéba conducted a series of trials with winegrowers in several major French wine-growing regions. The main objectives of this campaign were to demonstrate the effectiveness of AXPERA, its innovative biological solution, and to validate its reliability in local programmes and practical conditions. We saw results incorporating AXPERA into vineyards' treatment programme that has enabled them to reduce copper input w...

10/02/25 October 2, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch